HCRN-GU22-587
Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial (ARCITECT)
Status: Open to Accrual
Learn more:
Study Contact: studies@hoosiercancer.org; (317) 921-2050.
Abstracts/Posters/Presentations:
- M Serzan, O Jegede, R Alter, M Asim Bilen, D Braun, D Einstein, N Haas, H Hammers, D Herchenhorn, J King, K Runcie, J Sosman, C Sternberg, Y Yang, T Choueiri, S Signoretti, MB Atkins. Advanced renal cell cancer combination immunotherapy clinical trial (ARCITECT; HCRN GU 22-587). Poster Presentation, 2024 ASCO. See abstract.
- M Serzan, O Jegede, R Alter, M Asim Bilen, D Braun, D Einstein, N Haas, H Hammers, D Herchenhorn, J King, K Runcie, J Sosman, C Sternberg, Y Yang, T Choueiri, S Signoretti, MB Atkins. Advanced renal cell cancer combination immunotherapy clinical trial (ARCITECT; HCRN GU 22-587). Trials in Progress, 2024 ASCO GU. See abstract.
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter